2-Bromo-1-(bromomethyl)-3-iodobenzene, 95.0%, 250mg

2,3,5,6-Tetrabromocyclohexa-2,5-diene-1,4-dione, 97%, 25g

Methyl (4-oxocyclohexyl)carbamic acid tert-butyl ester, 95.0%, 5g

2-(4-(TRIFLUOROMETHYL)PHENOXY)PROPANAMIDE, 95.0%, 250mg

(3R,5R)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride, 97.0%, 1g

6-FLUORO-2-METHYL-3-NITROBENZOIC ACID, 95.0%, 25g

2,3-(Methylenedioxy)benzaldehyde>97.0%(GC)1g

1-(2,4-Dimethylphenyl)-3,5-diphenyl-1H-pyrazole, 95+%, 100mg

Fmoc-(S)-3-Amino-4-(4-bromo-phenyl)-butyric acid, 97%, 10g

GC capillary column ROTI®Cap-624, 50 m, 0.32 mm, 1.80 µm, 1 Piece(s)

3-Phenylazetidin-3-ol hydrochloride, 95.0%, 25g

4-Bromo-2-fluorobenzenesulfonyl chloride, 98.0%, 5g

2-(3-(trifluoromethyl)phenyl)-4,5-dihydrooxazole, 96%, 2g